tradingkey.logo
tradingkey.logo
Search

Health Catalyst slips; Piper Sandler downgrades to 'neutral'

ReutersAug 27, 2025 10:47 AM
facebooktwitterlinkedin

Shares of healthcare tech firm Health Catalyst HCAT.O down 3.7% at $3.37 premarket

Piper Sandler downgrades stock to "neutral" from "overweight"

Cuts target price to $4 from $8, implying a 14.3% premium from the stock's last close

Piper cites lack of organic growth drivers that can indicate revenue growth recovery and create shareholder value

Notes, the CY25 revenue "guide-down removes all organic growth from the outlook and HCAT now expects CY26 revenue to decline y/y"

HCAT cut its CY2025 revenue outlook to $310 million from its previous forecast of $335 million

Average rating of 12 analysts is "hold", with a median PT of $5 - data compiled by LSEG

As of last close, HCAT down nearly 51% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI